Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in Pathology

Retrieve available abstracts of 14 articles:
HTML format
Text format



Single Articles


    January 2017
  1. SIMMONS A, Burrage PM, Nicolau DV Jr, Lakhani SR, et al
    Environmental factors in breast cancer invasion: a mathematical modelling review.
    Pathology. 2017 Jan 9. pii: S0031-3025(16)40507.
    PubMed     Text format     Abstract available


  2. PENAULT-LLORCA F, Radosevic-Robin N
    Ki67 assessment in breast cancer: an update.
    Pathology. 2017 Jan 5. pii: S0031-3025(16)40573.
    PubMed     Text format     Abstract available


    December 2016
  3. LUEN SJ, Savas P, Fox SB, Salgado R, et al
    Tumour-infiltrating lymphocytes and the emerging role of immunotherapy in breast cancer.
    Pathology. 2016 Dec 31. pii: S0031-3025(16)40413.
    PubMed     Text format     Abstract available


  4. MCCUAIG R, Wu F, Dunn J, Rao S, et al
    The biological and clinical significance of stromal-epithelial interactions in breast cancer.
    Pathology. 2016 Dec 29. pii: S0031-3025(16)40368.
    PubMed     Text format     Abstract available


  5. RAKHA EA, Green AR
    Molecular classification of breast cancer: what the pathologist needs to know.
    Pathology. 2016 Dec 28. pii: S0031-3025(16)40365.
    PubMed     Text format     Abstract available


  6. ROSS JS, Gay LM
    Comprehensive genomic sequencing and the molecular profiles of clinically advanced breast cancer.
    Pathology. 2016 Dec 26. pii: S0031-3025(16)40362.
    PubMed     Text format     Abstract available


  7. ALI R, Rakha EA, Madhusudan S, Bryant HE, et al
    DNA damage repair in breast cancer and its therapeutic implications.
    Pathology. 2016 Dec 26. pii: S0031-3025(16)40417.
    PubMed     Text format     Abstract available


    August 2016
  8. MOREY AL, Brown B, Farshid G, Fox SB, et al
    Determining HER2 (ERBB2) amplification status in women with breast cancer: final results from the Australian in situ hybridisation program.
    Pathology. 2016 Aug 23. pii: S0031-3025(16)38281.
    PubMed     Text format     Abstract available


    February 2016
  9. KEEMAN H, Harris GC
    An audit of frontline (F)ISH testing outside the Australian setting on HER2 positivity rates in breast cancer and the impact of the 2013 ASCO guidelines.
    Pathology. 2016;48 Suppl 1:S61.
    PubMed     Text format    


  10. SHUI R, Yu B, Bi R, Yang F, et al
    An interobserver reproducibility analysis of ki67 visual assessment in breast cancer.
    Pathology. 2016;48 Suppl 1:S155-S156.
    PubMed     Text format    


  11. BECKERS RK, Selinger C, Vilain R, Madore J, et al
    PDl1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome.
    Pathology. 2016;48 Suppl 1:S146-S147.
    PubMed     Text format    


  12. MUSTOKOWENI S
    The profile of immunohistochemistry test for breast cancer in Dr Soetomo Hospital Surabaya, Indonesia.
    Pathology. 2016;48 Suppl 1:S145.
    PubMed     Text format    


  13. GWAK JM, Kim HJ, Kim EJ, Park SY, et al
    Clinicopathologic significance of MIR-221/222 expression in breast cancer.
    Pathology. 2016;48 Suppl 1:S128.
    PubMed     Text format    


  14. DIN TA, Seeni A, Yusoff MS, Shamsuddin S, et al
    PF4-Induced apoptosis in breast cancer in vivo study: The role of the caspases family.
    Pathology. 2016;48 Suppl 1:S122.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: